What is palmitoylethanolamide (PEA)?
Palmitoylethanolamide (PEA), the active compound in Levagen®+, is a naturally occurring fatty acid compound made by the body in response to physical stress. It’s been studied for its role in supporting comfort, recovery, sleep quality, immune function, and nervous system balance. Small amounts of PEA are also found naturally in foods such as egg yolks and peanuts.
Despite its potential, traditional forms of PEA are poorly absorbed in the digestive tract, limiting how effectively the body can use it. This is where formulation and delivery become critical.
Backed by 16 human clinical studies and more than six years of focused research, Levagen+® represents one of the most extensively researched and well-designed forms of PEA available - developed to overcome absorption challenges and deliver consistent, meaningful support.
Why Does PEA It Matter?
PEA works with the body’s own regulatory systems to help maintain balance and comfort, particularly in response to inflammation and nerve sensitivity.
Research suggests PEA plays a role in supporting:
- Inflammatory balance
- Joint and muscle comfort
- Sleep quality
- Immune function
- Nervous system and cognitive health
However, without effective absorption, even well-researched compounds like PEA may struggle to deliver their full benefits.
Why Standard PEA Falls Short
PEA is highly lipophilic - meaning it is fat-soluble and poorly disperses in water. As a result, much of standard PEA passes through the digestive system without entering circulation in meaningful amounts.
Increasing dose alone does not reliably solve this problem. Instead, bioavailability - how efficiently PEA is absorbed and utilised - is the true limiting factor.
What Makes Levagen+® Different?
Levagen+® is designed to address PEA’s absorption challenge using LipiSperse® delivery technology. This allows PEA to disperse more effectively, improving uptake and consistency of absorption.
Key differentiators include:
Enhanced absorption
Levagen+® demonstrates up to 1.75× greater bioavailability compared to standard PEA.
High active content
Each dose contains approximately 90% active PEA.
Clinically validated
Levagen+® is supported by 16 human clinical studies across multiple areas of health and wellbeing.
Cold-water dispersible
LipiSperse® technology improves dispersion and uptake without relying on high doses.
How Levagen+® Works in the Body
Levagen+® supports several biological pathways involved in comfort, recovery, and nervous system regulation.
Supports inflammatory balance via PPAR-α
PEA activates PPAR-α, a receptor involved in regulating inflammatory signalling and supporting cellular recovery.
Helps regulate mast cells and glial cells
These cells influence inflammation, discomfort, and nerve sensitivity. PEA helps regulate their activity, supporting overall comfort and nervous system balance.
Supports the endocannabinoid system (ECS)
The ECS plays a role in regulating mood, sleep, appetite, immune response, and pain perception. PEA supports ECS activity, helping maintain the body’s natural equilibrium.
Improved bioavailability for greater effectiveness
Levagen+®’s enhanced absorption allows PEA to circulate more efficiently, meaning meaningful effects can be achieved without excessive dosing.
Clinically Researched Benefits of Levagen+®
Backed by 16 human clinical studies, Levagen+® has been shown to support multiple aspects of health and wellbeing.
Joint Comfort & Mobility
A 2019 human study demonstrated improvements in joint comfort, stiffness, and function using 300–600 mg of PEA daily.
Exercise Recovery
A 2020 study reported reduced muscle soreness, faster recovery, and lower markers of exercise-induced muscle damage when taken before and after training.
Sleep & Immune Support
A 2021 study observed improvements in sleep latency, morning alertness, and cognitive performance on waking. A second 2021 study reported reduced cold and upper respiratory tract infection symptoms.
Neuropathic Support
A 2022 study demonstrated reductions in neuropathic discomfort, inflammatory cytokines, and improvements in mood and sleep quality.
Cognitive Health
A 2024 study showed increases in BDNF (brain-derived neurotrophic factor), alongside improvements in memory and task performance.
Emerging Research
Additional studies continue to explore PEA’s potential across a broader range of applications, including:
- Migraine frequency and severity (2024)
- Gut and metabolic health markers (2025)
- Seasonal allergies (2023)
- Menstrual discomfort (2025)
- Stress resilience and heart rate variability (2025)
Supporting Healthspan Through Smarter Formulation
Levagen+® combines natural biology with modern nutritional science to deliver PEA in a form the body can use effectively.
With enhanced absorption and extensive clinical research, it offers a considered, science-backed approach to supporting comfort, recovery, cognitive resilience, and long-term healthspan - helping the body function well today while supporting wellbeing over time.
Levagen®+ is one of the clinically studied actives at the heart of AEVUM Daily Vitals. Formulated at a purposeful dose for daily use, it contributes to the broader goal of long-term comfort, recovery and wellbeing support -- without complexity or excess. If you're looking to simplify your daily supplement routine without compromising on evidence, Daily Vitals is designed with exactly that in mind.
